PGO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Prostatype Genomics AB

Watchlist Manager

Watchlist

Price: 0.6475 EUR 4.44% Market Closed

Market Cap: €641.6m

	Prostatype Genomics AB F:PGO	SE
	Conifex Timber Inc TSX:CFF	CA
	Gamehost Inc TSX:GH	CA
	Noble Iron Inc XTSX:NIR	CA

Profitability Summary

Prostatype Genomics AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

392%

Declining Gross Margin

123% > 100%

Negative Operating Margin

-6 555%

Negative 3Y Average Operating Margin

-9 263%

Declining Operating Margin

-4 247% > -6 555%

Negative Net Margin

-7 492%

Negative 3Y Average Net Margin

-9 776%

Declining Net Margin

-4 291% > -7 492%

Negative Free Cash Flow Margin

-6 270%

Negative 3Y Average Free Cash Flow Margin

-10 527%

Declining Free Cash Flow Margin

-4 201% > -6 270%

Negative ROE

-148%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-135%

ROIC is Increasing

-211% > -113%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.